Pharmacogenetics: focus on pharmacodynamics

Author： Klaus L.   Elizabeth F.   Mark C.   Ian H.  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.15, Iss.2, 2001-04, pp. : 74-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lithium Pharmacodynamics and Pharmacogenetics: Focus on Inositol Mono Phosphatase (IMPase), Inositol Poliphosphatase (IPPase) and Glycogen Sinthase Kinase 3 Beta (GSK-3 Beta)

By  

Current Medicinal Chemistry, Vol. 16, Iss. 15, 2009-05 ,pp. : 1917-1948

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Pharmacogenetics: The Move from Pharmacokinetics to Pharmacodynamics

By  

Current Pharmacogenomics, Vol. 4, Iss. 1, 2006-03 ,pp. : 39-46

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs

By Sakaeda Toshiyuki   Nakamura Tsutomu   Okumura Katsuhiko  

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 397-410

Future Medicine

Access to resources Recommend Favorite

Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics

By Sehrt Daniel   Meineke Ingolf   Tzvetkov Mladen   Güültepe Senol   Brockmööller Jüürgen  

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 783-795

Future Medicine

Access to resources Recommend Favorite

Role of pharmacogenetics in variable response to drugs: focus on opioids

By Kadiev Esin   Patel Vipul   Rad Pouya   Thankachan Lovely   Tram Abby   Weinlein Meg   Woodfin Kristin   Raffa Robert B   Nagar Swati  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 77-91

Informa Healthcare

Access to resources Recommend Favorite